| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0169-4758(93)90144-5 |
| P698 | PubMed publication ID | 15463750 |
| P50 | author | Jacqueline A. Upcroft | Q111307278 |
| Peter Upcroft | Q111307298 | ||
| P433 | issue | 5 | |
| P921 | main subject | drug resistance | Q12147416 |
| P304 | page(s) | 187-190 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Parasitology Today | Q45895401 |
| P1476 | title | Drug resistance and Giardia. | |
| P478 | volume | 9 |
| Q28481230 | A data-driven predictive approach for drug delivery using machine learning techniques |
| Q21144530 | A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis |
| Q34528996 | A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities |
| Q50470500 | A simple colourimetric method to determine anti-giardial activity of drugs. |
| Q34460598 | Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis |
| Q48066310 | Analysis of nucleotide variation within the triose-phosphate isomerase gene of Giardia duodenalis from sheep and its zoonotic implications |
| Q37260581 | Barcoding of Giardia duodenalis isolates and derived lines from an established cryobank by a mutation scanning-based approach |
| Q37524185 | Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new antiamebic drugs |
| Q34601985 | Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites |
| Q37390538 | Current treatment options for Dientamoeba fragilis infections. |
| Q34481652 | Diagnostic advantages and therapeutic options for giardiasis |
| Q32156246 | Drug resistance among malaria and other parasites |
| Q79340355 | Drug resistance in Giardia: clinical versus laboratory isolates |
| Q35219218 | Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis |
| Q33982334 | Drug susceptibility testing of anaerobic protozoa |
| Q24550694 | Drug targets and mechanisms of resistance in the anaerobic protozoa |
| Q81376730 | Effect of metronidazole analogues on Giardia lamblia cultures |
| Q46459928 | Efficacy of Drontal Flavour Plus (50 mg praziquantel, 144 mg pyrantel embonate, 150 mg febantel per tablet) against Giardia sp in naturally infected dogs |
| Q35570972 | Efficacy of antigiardial drugs |
| Q33975866 | Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp |
| Q42116901 | Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia |
| Q35270323 | Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia |
| Q87637133 | In vitro antiamoebic activity evaluation and docking studies of metronidazole-triazole hybrids |
| Q71959500 | In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay |
| Q24519052 | Induction of resistance to azole drugs in Trypanosoma cruzi |
| Q40882604 | Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme |
| Q38233620 | Management of chronic Giardia infection |
| Q47792293 | Management of giardiasis by a herbal drug 'Pippali Rasayana': a clinical study |
| Q39580129 | Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase |
| Q47758372 | My favorite cell: Giardia |
| Q41352700 | Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
| Q64880222 | On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug. |
| Q38192001 | Parasitic diseases in travelers: a focus on therapy |
| Q35569960 | Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance |
| Q36722931 | Physical map of a 2 Mb chromosome of the intestinal protozoan parasite Giardia duodenalis |
| Q53685914 | Physiological aspects of nitro drug resistance in Giardia lamblia. |
| Q33286954 | Replacement of the essential Dictyostelium Arp2 gene by its Entamoeba homologue using parasexual genetics |
| Q64087646 | Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics |
| Q44207196 | Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. |
| Q46577880 | The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro |
| Q41333897 | The mechanisms of action of antiprotozoal and anthelmintic drugs in man. |
| Q37010853 | The public health and clinical significance of Giardia and Cryptosporidium in domestic animals |
| Q55034504 | Treatment of giardiasis. |
| Q34491543 | Zoonotic potential and molecular epidemiology of Giardia species and giardiasis |
| Q54011056 | [Trichomonas vaginalis: treatment and resistance to nitroimidazoles]. |
Search more.